Overview
- UnitedHealth reported second-quarter adjusted earnings of $6.38 per share and revenue of about $112.03 billion, both above Wall Street expectations, which the company disclosed Thursday.
- The company raised full-year adjusted earnings guidance to $19.50–$20.00 per share and increased its cash flow outlook after the stronger-than-expected quarter.
- UnitedHealth’s medical-cost ratio improved to 86.7% from 89.4% a year earlier as management cited tighter pricing, benefit-design changes, a healthier member mix and operational savings from AI tools that speed prior authorizations and improve payment accuracy.
- Membership declined to roughly 48.5 million, down about 525,000 from the prior quarter, a fall the company attributes to exits from unprofitable markets and affordability pressures; UnitedHealth also noted it has no new updates on the ongoing DOJ investigation into Medicare billing.
- Investors reacted positively with shares jumping about 7% in premarket trading, but analysts warn structural risks remain including industry-wide elevated medical costs, continued membership churn and regulatory uncertainty that will determine whether improvement is durable.